Antimicrobial resistance of bacterial pathogens isolated from cancer patients: a systematic review and meta-analysis
Antimicrobial resistance (AMR) poses a significant threat to global public health, particularly for cancer patients. A comprehensive review of bacterial pathogens isolated from cancer patients found that resistance prevalence was highest for penicillins in E. coli, followed by cotrimoxazole and monobactams in K. pneumoniae. Acinetobacter baumannii had high resistance prevalence to multiple antimicrobial classes, while Enterobacter spp. and Enterococcus faecium showed high resistance prevalence to penicillins. The high prevalence of AMR, especially among ESKAPE pathogens, highlights the urgent need for improved infection prevention and antimicrobial stewardship in cancer care.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!